DR. RAFFERTY & PARTNERS
BALLYCLARE GROUP PRACTICE, BALLYCLARE GROUP PRACTICE, BALLYCLARE HEALTH CENTRE, GEORGE AVENUE, BALLYCLARE
HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 23 | 26 | 88.5% | |
| HF 4 | 2011 | 20 | 24 | 83.3% | |
| HF 4 | 2012 | 17 | 21 | 81.0% | |
| HF 4 | 2013 | 17 | 22 | 77.3% | |
| HF004 | 2014 | 12 | 14 | 85.7% | |
| HF004 | 2015 | 18 | 19 | 94.7% | |
| HF004 | 2016 | 18 | 19 | 94.7% | |
| HF004 | 2017 | 18 | 20 | 90.0% | |
| HF004 | 2018 | 21 | 22 | 95.5% | |
| HF004 | 2019 | 20 | 21 | 95.2% | |
| HF004 | 2020 | 27 | 28 | 96.4% | |
| HF004 | 2021 | 29 | 33 | 87.9% |
